About Personalis, Inc.
Personalis, Inc. is a United States–based genomics and precision medicine company that develops advanced genomic sequencing and molecular testing solutions for oncology, population health, and life sciences research. The company provides next-generation sequencing (NGS) services, comprehensive genomic profiling, liquid biopsy testing, minimal residual disease (MRD) detection, immunogenomics, and bioinformatics solutions to support cancer diagnosis, treatment selection, disease monitoring, and clinical research. Its proprietary platforms integrate genomic data with advanced analytics to enable precision medicine applications for biopharmaceutical companies, healthcare providers, government agencies, and academic research institutions. Personalis also collaborates with pharmaceutical and biotechnology companies to support biomarker discovery, companion diagnostics, and clinical trial development. The company was founded in 2011 as a spinout from Stanford University and is headquartered in Fremont, California, United States.